Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page history now lists a new release tag v3.6.4. This indicates a software update to the site reflected in the record history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page history now lists Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, following the previous v3.6.0 entry. This documents an incremental update to the record on the ClinicalTrials.gov page.SummaryDifference0.1%

- Check53 days agoChange DetectedNew entries appear in the study record history: 'Check who can join' and 'Find Contact Information', and the page revision now shows v3.6.0 (with v3.5.5 removed).SummaryDifference0.3%

- Check60 days agoChange DetectedThe study history now shows a new revision entry (v3.5.5) as the latest update, replacing the previous revision (v3.5.4) in the list.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history now shows a new latest revision entry labeled v3.5.4. This replaces the previous v3.5.3 and indicates a minor update to the page’s revision history for this study.SummaryDifference0.1%

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.